designer virus

A Phase I clinical trial of an experimental anticancer drug has begun, using a specialized virus designed to selectively attack the cells that make up the targeted tumor. A separate cancer study has also produced the unprecedented—yet very welcome—outcome of successfully treating the cancer that was present in all ofread more